140 related articles for article (PubMed ID: 9894763)
1. Neutron capture therapy with a new boron-porphyrin compound in the rat 9L glioma model.
Shibata Y; Matsumura A; Yamamoto T; Nakagawa K; Yoshii Y; Nose T; Sakata I; Nakajima S; Hayakawa Y; Ono K
J Exp Clin Cancer Res; 1998 Sep; 17(3):285-9. PubMed ID: 9894763
[TBL] [Abstract][Full Text] [Related]
2. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
3. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
Morris GM; Micca PL; Coderre JA
Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
[TBL] [Abstract][Full Text] [Related]
4. Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy.
Smith DR; Chandra S; Coderre JA; Morrison GH
Cancer Res; 1996 Oct; 56(19):4302-6. PubMed ID: 8813111
[TBL] [Abstract][Full Text] [Related]
5. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
Clin Cancer Res; 2000 Feb; 6(2):725-30. PubMed ID: 10690559
[TBL] [Abstract][Full Text] [Related]
6. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):247-52. PubMed ID: 16111595
[TBL] [Abstract][Full Text] [Related]
7. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of single-dose and fractionated boron neutron capture therapy.
Coderre JA; Morris GM; Micca PL; Fisher CD; Ross GA
Radiat Res; 1995 Dec; 144(3):310-7. PubMed ID: 7494875
[TBL] [Abstract][Full Text] [Related]
9. Derivations of relative biological effectiveness for the high-let radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo.
Coderre JA; Makar MS; Micca PL; Nawrocky MM; Liu HB; Joel DD; Slatkin DN; Amols HI
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1121-9. PubMed ID: 8262837
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy of the rat 9L gliosarcoma: evaluation of the effects of shark cartilage.
Morris GM; Coderre JA; Micca PL; Lombardo DT; Hopewell JW
Br J Radiol; 2000 Apr; 73(868):429-34. PubMed ID: 10844870
[TBL] [Abstract][Full Text] [Related]
11. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
[TBL] [Abstract][Full Text] [Related]
12. A new boronated porphyrin (STA-BX909) for neutron capture therapy: an in vitro survival assay and in vivo tissue uptake study.
Matsumura A; Shibata Y; Yamamoto T; Yoshida F; Isobe T; Nakai K; Hayakawa Y; Kiriya M; Shimojo N; Ono K; Sakata I; Nakajima S; Okumura M; Nose T
Cancer Lett; 1999 Jul; 141(1-2):203-9. PubMed ID: 10454263
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
[TBL] [Abstract][Full Text] [Related]
14. Early effects of boron neutron capture therapy on rat glioma models.
Nakagawa N; Akai F; Fukawa N; Fujita Y; Suzuki M; Ono K; Taneda M
Brain Tumor Pathol; 2007; 24(1):7-13. PubMed ID: 18095138
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
16. Boron-containing polyamines as DNA targeting agents for neutron capture therapy of brain tumors: synthesis and biological evaluation.
Cai J; Soloway AH; Barth RF; Adams DM; Hariharan JR; Wyzlic IM; Radcliffe K
J Med Chem; 1997 Nov; 40(24):3887-96. PubMed ID: 9397169
[TBL] [Abstract][Full Text] [Related]
17. Selective ablation of rat brain tumors by boron neutron capture therapy.
Coderre J; Rubin P; Freedman A; Hansen J; Wooding TS; Joel D; Gash D
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1067-77. PubMed ID: 8175391
[TBL] [Abstract][Full Text] [Related]
18. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA
Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179
[TBL] [Abstract][Full Text] [Related]
19. In vivo gadolinium neutron capture therapy using a potentially effective compound (Gd-BOPTA).
Matsumura A; Zhang T; Yamamoto T; Yoshida F; Sakurai Y; Shimojo N; Nose T
Anticancer Res; 2003; 23(3B):2451-6. PubMed ID: 12894527
[TBL] [Abstract][Full Text] [Related]
20. Boron neutron capture therapy: effects of split dose and overall treatment time.
Morris GM; Micca PL; Rezvani M; Hopewell JW; Coderre JA
J Neurooncol; 2001 Apr; 52(2):101-10. PubMed ID: 11508809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
